Treating thalassemia major-related iron overload: the role of deferiprone

Article Properties
Cite
Berdoukas, Vasili. “Treating Thalassemia Major-Related Iron Overload: The Role of Deferiprone”. Journal of Blood Medicine, 2012, p. 119, https://doi.org/10.2147/jbm.s27400.
Berdoukas, V. (2012). Treating thalassemia major-related iron overload: the role of deferiprone. Journal of Blood Medicine, 119. https://doi.org/10.2147/jbm.s27400
Berdoukas, Vasili. “Treating Thalassemia Major-Related Iron Overload: The Role of Deferiprone”. Journal of Blood Medicine, 2012, 119. https://doi.org/10.2147/jbm.s27400.
Berdoukas V. Treating thalassemia major-related iron overload: the role of deferiprone. Journal of Blood Medicine. 2012;:119.
Journal Category
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the blood and blood-forming organs
Citations Analysis
Category Category Repetition
Science: Biology (General): Cytology1
The category Science: Biology (General): Cytology 1 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Treatment ofβ-Thalassemia/Hemoglobin E with Antioxidant Cocktails Results in Decreased Oxidative Stress, Increased Hemoglobin Concentration, and Improvement of the Hypercoagulable State and was published in 2015. The most recent citation comes from a 2018 study titled Are Mangiferin and Mangiferin-Containing Plant Extracts Helpful for Iron-Loaded Transfusion-Dependent and Non-Transfusion-Dependent Thalassaemia Patients?. This article reached its peak citation in 2018, with 1 citations. It has been cited in 2 different journals. Among related journals, the Biomedical and Pharmacology Journal cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year